Cargando…
Ticagrelor effectively inhibits platelet aggregation in comatose survivors of cardiac arrest undergoing primary percutaneous coronary intervention treated with mild therapeutic hypothermia
BACKGROUND: Mild therapeutic hypothermia (MTH) is believed to reduce the effectiveness of antiplatelet drugs. Effective dual-antiplatelet therapy after percutaneous coronary intervention (PCI) is mandatory to avoid acute stent thrombosis. The effectiveness of ticagrelor in MTH-treated out-of-hospita...
Autores principales: | Tomala, Marek T., Trąbka-Zawicki, Aleksander, Machnik, Andrzej, Nawrotek, Bartłomiej A., Zajdel, Wojciech, Stępień, Ewa Ł., Legutko, Jacek, Żmudka, Krzysztof |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Via Medica
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508063/ https://www.ncbi.nlm.nih.gov/pubmed/34165181 http://dx.doi.org/10.5603/CJ.a2021.0064 |
Ejemplares similares
-
Adaptation of global hemostasis to therapeutic hypothermia in patients with out-of-hospital cardiac arrest: Thromboelastography study
por: Trąbka-Zawicki, Aleksander, et al.
Publicado: (2019) -
Chemokine RANTES and IL-1β in mild therapeutic hypothermia-treated patients after out-of-hospital sudden cardiac arrest
por: Podolec, Jakub, et al.
Publicado: (2019) -
Platelet aggregation and clot formation in comatose survivors of cardiac arrest treated with induced hypothermia and dual platelet inhibition with aspirin and ticagrelor; a prospective observational study
por: Kander, Thomas, et al.
Publicado: (2014) -
Neurological Prognostications for the Therapeutic Hypothermia among Comatose Survivors of Cardiac Arrest
por: Kongpolprom, Napplika, et al.
Publicado: (2018) -
Mild therapeutic hypothermia or targeted temperature management for cardiac arrest survivors?
por: Kubica, Jacek, et al.
Publicado: (2022)